Explainer: CNBS

The active marijuana ETF had an interesting year.

Reviewed by: Heather Bell
Edited by: Heather Bell

Each month, we look at an ETF selected by ETF.com based on its performance and importance to investors. This month, we consider the performance of the $135.8 million Amplify Seymour Cannabis ETF (CNBS), a top-performing actively managed marijuana ETF. All the companies mentioned below are holdings in CNBS, unless otherwise noted (*).



For a larger view, please click on the image above.


MAR 9 Village Farms International settles its ownership dispute with Emerald Health Therapeutics over Pure Sunfarms, a cannabis producer, after six months.

MAY 28 Canopy Growth sees its price spike in advance of its May 29 earnings report, only to fall sharply after the report reveals disappointing year-over-year results.

AUG 6 The stock price of marijuana grower Cronos Group plunges after it reports a $107 million net loss for its second quarter.

OCT 12 Aphria sees a 10% increase in its share price after then-vice presidential candidate Kamala Harris says that Joe Biden would decriminalize marijuana as president.

DEC 10 Blank-check firm Silver Spike Acquisition shares jump nearly 50% after the company announced it would merge with marijuana e-commerce platform Weedmaps.

FEB 3 GW Pharmaceuticals sees its stock skyrocket 46% after news breaks that it will be acquired by Jazz Pharma for $7.2 billion.

Source: Bloomberg; data for 2/28/2020-2/26/2021

Heather Bell is a former managing editor of etf.com. She has also held editorial positions at Dow Jones Indexes and Lehman Brothers. Bell is a graduate of Dartmouth college and resides in the Denver area with her two dogs.